The pharmacology of statins.
Sirtori CR.
Pharmacol Res. 2014 Oct;88:3-11. doi: 10.1016/j.phrs.2014.03.002. Epub 2014 Mar 20.
Clinical management of patients with drug-induced liver injury (DILI).
Björnsson ES.
United European Gastroenterol J. 2021 Sep;9(7):781-786. doi: 10.1002/ueg2.12113. Epub 2021 Jun 28.
Statin Intolerance.
Brown AS, Watson KE.
Rev Cardiovasc Med. 2018;19(S1):S9-S19. doi: 10.3909/ricm19S1S0005.
Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
Yebyo HG, Aschmann HE, Kaufmann M, Puhan MA.
Am Heart J. 2019 Apr;210:18-28. doi: 10.1016/j.ahj.2018.12.007. Epub 2019 Jan 10.
Lipid-lowering agents and hepatotoxicity.
Demyen M, Alkhalloufi K, Pyrsopoulos NT.
Clin Liver Dis. 2013 Nov;17(4):699-714, x. doi: 10.1016/j.cld.2013.07.016.
Traditional and novel non-statin lipid-lowering drugs.
Jain P.
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S38-S43. doi: 10.1016/j.ihj.2023.11.003. Epub 2023 Nov 17.
Toxin-induced hepatic injury.
Lopez AM, Hendrickson RG.
Emerg Med Clin North Am. 2014 Feb;32(1):103-25. doi: 10.1016/j.emc.2013.09.005.
Hepatotoxicity of statins and other lipid-lowering agents.
Björnsson ES.
Liver Int. 2017 Feb;37(2):173-178. doi: 10.1111/liv.13308. Epub 2016 Nov 27.
Drug-induced liver injury.
Leise MD, Poterucha JJ, Talwalkar JA.
Mayo Clin Proc. 2014 Jan;89(1):95-106. doi: 10.1016/j.mayocp.2013.09.016.
Lipid lowering medication and hepatotoxicity.
Kinnman N, Hultcrantz R.
J Intern Med. 2001 Sep;250(3):183-5. doi: 10.1046/j.1365-2796.2001.00887.x.
